Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, Fučíková J, Truxová I, Tachezy R, Špíšek R, Fialová A

. 2015 ; 4 (1) : e965570.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc19040695

Grantová podpora
NT11542 MZ0 CEP - Centrální evidence projektů

Human papillomavirus (HPV) infection is one of the most important etiologic causes of oropharyngeal head and neck squamous cell carcinoma (HNSCC). Patients with HPV-positive HNSCC were reported to have a better clinical outcome than patients with HPV-negative cancers. However, little is known about the possible causes of different clinical outcomes. In this study, we analyzed a detailed immune profile of tumor samples from HNSCC patients with respect to their HPV status. We analyzed the characteristics of immune cell infiltrates, including the frequency and distribution of antigen-presenting cells and naïve, regulatory and effector T cells and the cytokine and chemokine levels in tumor tissue. There was a profound difference in the extent and characteristics of intratumoral immune cell infiltrates in HNSCC patients based on their HPV status. In contrast to HPV-negative tumor tissues, HPV-positive tumor samples showed significantly higher numbers of infiltrating IFNγ+ CD8+ T lymphocytes, IL-17+ CD8+ T lymphocytes, myeloid dendritic cells and proinflammatory chemokines. Furthermore, HPV-positive tumors had significantly lower expression of Cox-2 mRNA and higher expression of PD1 mRNA compared to HPV-negative tumors. The presence of a high level of intratumoral immune cell infiltrates might play a crucial role in the significantly better response of HPV-positive patients to standard therapy and their favorable clinical outcome. Furthermore, characterization of the HNSCC immune profile might be a valuable prognostic tool in addition to HPV status and might help identify novel targets for therapeutic strategies, including cancer immunotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19040695
003      
CZ-PrNML
005      
20200123130229.0
007      
ta
008      
191120s2015 xxu f 000 0|eng||
009      
AR
024    0_
$a 10.4161/21624011.2014.965570 $2 doi
035    __
$a (Pubmed)25949860
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Partlová, Simona $7 _AN085265 $u Sotio, Prague , Czech Republic ; Department of Immunology; 2nd Faculty of Medicine; Charles University; Motol University Hospital ; Prague, Czech Republic
245    10
$a Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma / $c Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, Fučíková J, Truxová I, Tachezy R, Špíšek R, Fialová A
520    9_
$a Human papillomavirus (HPV) infection is one of the most important etiologic causes of oropharyngeal head and neck squamous cell carcinoma (HNSCC). Patients with HPV-positive HNSCC were reported to have a better clinical outcome than patients with HPV-negative cancers. However, little is known about the possible causes of different clinical outcomes. In this study, we analyzed a detailed immune profile of tumor samples from HNSCC patients with respect to their HPV status. We analyzed the characteristics of immune cell infiltrates, including the frequency and distribution of antigen-presenting cells and naïve, regulatory and effector T cells and the cytokine and chemokine levels in tumor tissue. There was a profound difference in the extent and characteristics of intratumoral immune cell infiltrates in HNSCC patients based on their HPV status. In contrast to HPV-negative tumor tissues, HPV-positive tumor samples showed significantly higher numbers of infiltrating IFNγ+ CD8+ T lymphocytes, IL-17+ CD8+ T lymphocytes, myeloid dendritic cells and proinflammatory chemokines. Furthermore, HPV-positive tumors had significantly lower expression of Cox-2 mRNA and higher expression of PD1 mRNA compared to HPV-negative tumors. The presence of a high level of intratumoral immune cell infiltrates might play a crucial role in the significantly better response of HPV-positive patients to standard therapy and their favorable clinical outcome. Furthermore, characterization of the HNSCC immune profile might be a valuable prognostic tool in addition to HPV status and might help identify novel targets for therapeutic strategies, including cancer immunotherapy.
650    _2
$a nádory hlavy a krku $7 D006258
650    12
$a dlaždicobuněčné karcinomy hlavy a krku $x etiologie $x imunologie $7 D000077195
650    12
$a infekce papilomavirem $x imunologie $7 D030361
650    12
$a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
650    12
$a antigeny CD279 $7 D061026
650    _2
$a lidé $7 D006801
650    _2
$a tumor infiltrující lymfocyty $7 D016246
700    1_
$a Bouček, Jan, $d 1976- $7 xx0100852 $u Department of Otorhinolaryngology and Head and Neck Surgery; 1st Faculty of Medicine; Charles University and Motol University Hospital ; Prague, Czech Republic ; Institute of Microbiology ASCR ; Prague, Czech Republic
700    1_
$a Kloudová, Kamila, $d 1989- $7 xx0240740 $u Sotio, Prague , Czech Republic ; Department of Immunology; 2nd Faculty of Medicine; Charles University; Motol University Hospital ; Prague, Czech Republic
700    1_
$a Lukešová, Eva $7 _AN076650 $u Department of Experimental Virology; Institute of Hematology and Blood Transfusion ; Prague, Czech Republic ; Department of Genetics and Microbiology; Faculty of Science; Charles University ; Prague, Czech Republic
700    1_
$a Zábrodský, Michal, $d 1974- $7 xx0101033 $u Department of Otorhinolaryngology and Head and Neck Surgery; 1st Faculty of Medicine; Charles University and Motol University Hospital ; Prague, Czech Republic
700    1_
$a Grega, Marek $7 xx0209713 $u Department of Pathology and Molecular Medicine; 2nd Faculty of Medicine; Charles University and Motol University Hospital ; Prague, Czech Republic
700    1_
$a Fučíková, Jitka, $d 1983- $7 xx0116819 $u Sotio, Prague , Czech Republic ; Department of Immunology; 2nd Faculty of Medicine; Charles University; Motol University Hospital ; Prague, Czech Republic
700    1_
$a Truxová, Iva $7 xx0238532 $u Sotio, Prague , Czech Republic
700    1_
$a Tachezy, Ruth $7 xx0060363 $u Department of Experimental Virology; Institute of Hematology and Blood Transfusion ; Prague, Czech Republic ; Department of Genetics and Microbiology; Faculty of Science; Charles University ; Prague, Czech Republic
700    1_
$a Špíšek, Radek, $d 1975- $7 nlk20030145288 $u Sotio, Prague , Czech Republic ; Department of Immunology; 2nd Faculty of Medicine; Charles University; Motol University Hospital ; Prague, Czech Republic
700    1_
$a Fialová, Anna, $d 1981- $7 stk2007393943 $u Sotio, Prague , Czech Republic ; Department of Immunology; 2nd Faculty of Medicine; Charles University; Motol University Hospital ; Prague, Czech Republic
773    0_
$t Oncoimmunology $x 2162-4011 $g Roč. 4, č. 1 (2015), s. e965570 $w MED00190079
910    __
$a ABA008 $y p $z 0
990    __
$a 20191120083722 $b ABA008
991    __
$a 20200123130607 $b ABA008
999    __
$a ok $b bmc $g 1466619 $s 1079295
BAS    __
$a 3
BMC    __
$a 2015 $b 4 $c 1 $d e965570 $x MED00190079 $i 2162-4011 $m Oncoimmunology
GRA    __
$a NT11542 $p MZ0
LZP    __
$a NLK 2019/lp

Najít záznam

Citační ukazatele

Možnosti archivace